Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA
Clinical trial NCT04539119 · UNKNOWN
Trial details
- NCT number
- NCT04539119
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2022-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.